Global Ultrasonic Lithotripter Market Size By Type (Intracorporeal Lithotripter, Extracorporeal Lithotripter), By Application (Hospital, Clinic), By Region, And Segment Forecasts, 2023 to 2032

lobal Ultrasonic Lithotripter Market Report Description

The Global Ultrasonic Lithotripter Market was valued at USD 450 million in 2023 and is projected to reach USD 768 million by 2031, growing at a CAGR of 6.8% during the forecast period from 2023 to 2031. Ultrasonic lithotripters are critical devices used to fragment kidney and ureteral stones, offering a non-invasive and efficient solution for urolithiasis treatment. The increasing prevalence of kidney stone disorders, advancements in minimally invasive surgical procedures, and the rising adoption of ultrasonic lithotripsy in hospitals and specialty clinics are key factors fueling market growth.

Drivers:

1. Growing Incidence of Urolithiasis:

Rising cases of kidney and urinary tract stones globally—driven by dietary factors, sedentary lifestyles, and dehydration—are significantly boosting the demand for ultrasonic lithotripters.

2. Advancements in Minimally Invasive Urology:

Technological developments in ultrasonic lithotripsy have improved treatment outcomes, reduced recovery time, and minimized complications, enhancing their acceptance among urologists.

3. Increasing Healthcare Expenditure:

Expanding healthcare budgets and infrastructure in emerging markets are driving the adoption of advanced urological devices, including ultrasonic lithotripters.

Restraints:

1. High Equipment Costs:

The initial acquisition cost and maintenance of ultrasonic lithotripters can be high, limiting accessibility for smaller hospitals, particularly in low-income regions.

2. Limited Awareness in Rural Areas:

In developing countries, limited access to specialized urological care and lack of awareness regarding advanced treatment options may hinder market penetration.

Opportunity:

1. Expanding Applications in Ambulatory Surgical Centers (ASCs):

The growing preference for outpatient procedures has increased the use of portable and compact ultrasonic lithotripters in ASCs.

2. Untapped Markets in Asia-Pacific and Africa:

Developing healthcare infrastructure and rising awareness offer significant growth opportunities for manufacturers in underpenetrated regions.

Market by System Type Insights:

The Standalone Ultrasonic Lithotripters segment accounted for the largest market share in 2023. Their portability, user-friendly design, and lower cost compared to integrated systems have made them highly popular in mid-sized hospitals and ASCs. However, the Integrated Ultrasonic Lithotripters segment is expected to witness the fastest growth due to increased adoption in high-volume urology centers offering combined imaging and treatment functionalities.

Market by End-use Insights:

In 2023, Hospitals emerged as the dominant end-user segment, capturing over 55% of the market share. Their extensive infrastructure, skilled personnel, and patient volume make hospitals the primary users of advanced lithotripsy technologies. Meanwhile, the Ambulatory Surgical Centers (ASCs) segment is projected to grow rapidly due to lower procedural costs and faster patient turnover.

Market by Regional Insights:

North America held the largest market share in 2023, driven by the high prevalence of kidney stones, advanced healthcare systems, and strong reimbursement policies. However, Asia-Pacific is expected to record the highest CAGR during the forecast period, propelled by increasing awareness, rising healthcare investments, and a growing aging population susceptible to urological disorders.

Competitive Scenario:

Leading players in the Global Ultrasonic Lithotripter Market include Olympus Corporation, Boston Scientific Corporation, EMS Electro Medical Systems S.A., DirexGroup, Siemens Healthineers, Karl Storz SE & Co. KG, Richard Wolf GmbH, and Medispec Ltd. These companies are focusing on product innovation, strategic collaborations, and market expansion.

Key Developments:

In 2024, Olympus launched a next-generation ultrasonic lithotripter system with enhanced stone localization and automatic power modulation.

In 2023, Boston Scientific collaborated with regional healthcare providers in Latin America to expand its distribution of minimally invasive urological solutions.

In 2022, Karl Storz introduced a compact ultrasonic lithotripter tailored for outpatient surgical environments in Europe and Asia.

Scope of Work – Global Ultrasonic Lithotripter Market

Report Metric Details

Market Size (2023) USD 450 million